Breaking News

Biotechs working on contraceptives weigh in on their work; Medicare aims to stop publishing some hospital safety data

 

Pharmalot Ed Silverman

STAT+: After abortion ruling, biotechs developing contraceptives say their work is more important — and fraught — than ever

By Jonathan Wosen

Adobe

Companies are scrambling to accelerate research timelines and pressing insurers to cover approved products.

Read More

STAT+: Medicare wants to stop publishing some hospital safety data next year

By Tara Bannow

STAT, photo courtesy Ann MacDonald

Hospitals were less safe during Covid, data show. And now Medicare wants to let hospitals keep more safety information hidden going forward.

Read More

STAT+: Up and down the ladder: The latest comings and goings

By Ed Silverman

Alex Hogan/STAT

From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.

Read More

STAT+: 'A slippery slope': Pfizer sells a contraceptive and donated to political groups that could come after the company

By Ed Silverman

APStock

A new analysis looks at pharma donations to political groups that could come after contraceptives.

Read More

Friday, July 1, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments